These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

99 related articles for article (PubMed ID: 9099484)

  • 1. Gallbladder visualization at twenty-four hours with octreotide scintigraphy. Potential false-positive finding.
    Kipper MS; Krohn LD
    Clin Nucl Med; 1997 Apr; 22(4):253-4. PubMed ID: 9099484
    [No Abstract]   [Full Text] [Related]  

  • 2. Improved visualization of carcinoid liver metastases by indium-111 pentetreotide scintigraphy following treatment with cold somatostatin analogue.
    Dörr U; Räth U; Sautter-Bihl ML; Guzman G; Bach D; Adrian HJ; Bihl H
    Eur J Nucl Med; 1993 May; 20(5):431-3. PubMed ID: 8100192
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary and follow-up studies of patients with carcinoid metastases using indium 111 octreotide--rational use of Sandostatin].
    Lipp RW; Hammer HF; Passath A; Dobnig H; Ramschak-Schwarzer S; Stiegler C; Leb G; Krejs GJ
    Acta Med Austriaca; 1993; 20(1-2):42-4. PubMed ID: 8475679
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Somatostatin analogue scintigraphy in carcinoid tumours.
    Kwekkeboom DJ; Krenning EP; Bakker WH; Oei HY; Kooij PP; Lamberts SW
    Eur J Nucl Med; 1993 Apr; 20(4):283-92. PubMed ID: 8491220
    [TBL] [Abstract][Full Text] [Related]  

  • 5. In-111 labeled octreotide imaging of a primary carcinoid lesion undetected by conventional imaging studies in a patient with "chronic pancreatitis".
    Kummar S; Kim SL; Halkar RK; Galt JR
    Clin Nucl Med; 1996 Aug; 21(8):634-7. PubMed ID: 8853917
    [TBL] [Abstract][Full Text] [Related]  

  • 6. In-111 octreotide scan in a case of a neuroendocrine tumor of unknown origin.
    Fuster D; Navasa M; Pons F; Vidal-Sicart S; Mateos JJ; Lomeña F; Rodes J; Herranz R
    Clin Nucl Med; 1999 Dec; 24(12):955-8. PubMed ID: 10595476
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Somatostatin receptor scintigraphy in medullary thyroid carcinomas, GEP and carcinoid tumors].
    Eising EG; Farahati J; Bier D; Knust EJ; Reiners C
    Nuklearmedizin; 1995 Feb; 34(1):1-7. PubMed ID: 7724358
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Bone scintigraphy and scintigraphy with (111)In-octreotide in the diagnosis of bone metastasis of bronchial carcinoid tumor].
    Pérez Angel F; Sánchez Catalicio J; Mohamed Salem L; Castellón Sánchez MI; Navarro Fernández JL; Claver Valderas MA
    Rev Esp Med Nucl; 2010; 29(1):38-9. PubMed ID: 19837486
    [No Abstract]   [Full Text] [Related]  

  • 9. Vasoactive intestinal peptide and somatostatin receptor scintigraphy for differential diagnosis of hepatic carcinoid metastasis.
    Kurtaran A; Raderer M; Müller C; Prokesch R; Kaserer K; Eibenberger K; Koperna K; Niederle B; Virgolini I
    J Nucl Med; 1997 Jun; 38(6):880-1. PubMed ID: 9189133
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A rare case of hepatic carcinoid.
    Tagliabue L; Tarolo GL; Bestetti A; Di Leo C; Del Sole A
    Clin Nucl Med; 2001 Oct; 26(10):893. PubMed ID: 11564944
    [No Abstract]   [Full Text] [Related]  

  • 11. Primary renal carcinoid tumor with liver metastases detected with somatostatin receptor imaging.
    Mufarrij P; Varkarakis IM; Studeman KD; Jarrett TW
    Urology; 2005 May; 65(5):1002. PubMed ID: 15882749
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Visualization of gallbladder with In-111 labeled octreotide in post prandial state.
    Gedik GK; Kiratli PO; Erbas B
    Ann Nucl Med; 2006 Oct; 20(8):557-60. PubMed ID: 17134024
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Somatostatin-receptor scintigraphy in the management of gastroenteropancreatic tumors.
    Krausz Y; Bar-Ziv J; de Jong RB; Ish-Shalom S; Chisin R; Shibley N; Glaser B
    Am J Gastroenterol; 1998 Jan; 93(1):66-70. PubMed ID: 9448177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Efficacy of octreotide in the regression of a metastatic carcinoid tumour despite negative imaging with In-111-pentetreotide (Octreoscan).
    Hillman N; Herranz L; Alvarez C; Martínez Olmos MA; Márco A; Gómez-Pan A
    Exp Clin Endocrinol Diabetes; 1998; 106(3):226-30. PubMed ID: 9710364
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gallbladder visualization with In-111 labeled octreotide.
    Krausz Y; Shibley N; De Jong RB; Yaffe S; Glaser B
    Clin Nucl Med; 1994 Feb; 19(2):133-5. PubMed ID: 8187397
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Somatostatin receptor scintigraphy. A new imaging procedure for the specific demonstration of carcinoids of the small intestine].
    Dörr U; Räth U; Schürmann G; Höring E; Bach D; Wurm K; Scholz M; Adrian HJ; Bihl H
    Rofo; 1993 Jan; 158(1):67-73. PubMed ID: 8425079
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Metastatic carcinoid tumor imaged with CT and a radiolabeled somatostatin analog: a case report.
    Lobrano MB; McCarthy K; Adams L; Neitzschman H
    Am J Gastroenterol; 1997 Mar; 92(3):513-5. PubMed ID: 9068482
    [TBL] [Abstract][Full Text] [Related]  

  • 18. False-negative fluorine-18-FDG PET in metastatic carcinoid.
    Jadvar H; Segall GM
    J Nucl Med; 1997 Sep; 38(9):1382-3. PubMed ID: 9293792
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 111In-octreotide scintigraphy in endocrine tumors. Preliminary data.
    Cremonini N; Furno A; Sforza A; Chiarini V; Graziano E; Zampa G; Turba E
    Q J Nucl Med; 1995 Dec; 39(4 Suppl 1):116-20. PubMed ID: 9002767
    [TBL] [Abstract][Full Text] [Related]  

  • 20. L-3-[123I]Iodo-alpha-methyltyrosine scintigraphy in carcinoid tumors: correlation with biochemical activity and comparison with [111In-DTPA-D-Phe1]-octreotide imaging.
    Jager PL; Meijer WG; Kema IP; Willemse PH; Piers DA; de Vries EG
    J Nucl Med; 2000 Nov; 41(11):1793-800. PubMed ID: 11079485
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.